colon News
-
Filtricine research on scientific conference for cancer treatment
At the AACR-NCI-EORTC conference for molecular targets (#Targets19) at Boston, we presented our latest preclinical research on treating colon cancer and boosting anti-PD-1 immunotherapy with our “targeted nutrient deprivation” ...
-
ANX ROBOTICA CORP RECEIVES 510(K) CLEARANCE FROM FDA TO MARKET ITS INTRAMARX™ RADIOPAQUE MARKERS
AnX Robotica Corp receives 510(k) clearance from FDA to market its IntraMarX™ Radiopaque Markers Plano, TX March 31st, 2020 – AnX Robotica Corp (AnX) today announced that it has received FDA 510(k) clearance to market its IntraMarX™ Radiopaque Markers (ROM). Radiopaque markers are used to measure colon transit time and they are the most basic and primary tool in evaluating ...
By AnX Robotica
-
Announcing Radiation (and Hemorrhagic) Cystitis Patient Registry: for people affected by pelvic radiation during cancer treatment.
Pittsburgh, PA – (May 9, 2022) – Lipella Pharmaceuticals, Inc. is announcing the Radiation Cystitis Patient Registry, an on-line patient registry program for people who are affected by pelvic radiation exposure, including survivors of pelvic cancers, such as prostate, uterine, cervical and colon cancer. ...
-
Endosomal Signaling Of Delta Opioid Receptors Is An Endogenous Mechanism And Therapeutic Target For Relief From Inflammatory Pain
Whether G protein-coupled receptors signal from endosomes to control important pathophysiological processes and are therapeutic targets is uncertain. We report that opioids from the inflamed colon activate δ-opioid receptors (DOPr) in endosomes of nociceptors. Biopsy samples of inflamed colonic mucosa from patients and mice with colitis released opioids that activated DOPr on nociceptors to ...
-
Obesity Primes the Colon for Cancer, According to NIH Study
Obesity, rather than diet, causes changes in the colon that may lead to colorectal cancer, according to a study in mice by the National Institutes of Health. The finding bolsters the recommendation that calorie control and frequent exercise are not only key to a healthy lifestyle, but a strategy to lower the risk for colon cancer, the second leading cause of cancer-related death in the United ...
-
NovaDigm Therapeutics Announces Initiation of Phase 2a Clinical Trial of NDV-3A in Staphylococcus aureus
BOSTON, MA – April 19, 2018 – NovaDigm Therapeutics, a company developing innovative immunotherapeutics and preventative vaccines for fungal and bacterial infections, today announced the initiation of a Phase 2a study evaluating NDV-3A for the reduction of Staphylococcus aureus (S. aureus) colonization in a high-risk population of military trainees. The study is being conducted with ...
-
Amadix has developed a blood-based to detect colorectal cancer up to 15 years in advance
Rocío Arroyo, researcher, and CEO of Amadix, leads the team that has created an innovative blood-based test that can detect if a healthy person will develop a malignant colon tumour in the future. As an entrepreneur, Rocío turned her scientific knowledge into a viable business model securing private investors in Castile and Leon to found Amadix. Amadix is today a small ...
By Amadix
-
Graftys adds a new distribution partnership in the US territory
GRAFTYS SA (“Graftys”), a global leader in resorbable bone cements, today announces a new distribution agreement for its bestselling product Graftys® QuickSet in the US territory. Responding to a medical need and to a direct request from orthopedic surgeons, Graftys® QuickSet, a new generation macroporous calcium phosphate cement which will be distributed in the USA under the ...
By Graftys
-
Exploring Biomarkers for Regorafenib Response in Metastatic Colorectal Cancer with the Precellys Evolution
Colorectal cancer affects the colon or rectum and is on the rise among young adults. Lifestyle factors like diet and physical inactivity may contribute to its incidence. Early detection through regular screenings is crucial for effective management. Awareness of symptoms and risk factors is essential for timely intervention. The 4th of February marks the World Cancer Day. In this publication, ...
-
Bladder Health Foundation Launches Patient Registry for Survivors of Pelvic Radiation Therapy
Pittsburgh, PA – (April 30, 2021) – The Bladder Health Foundation announces the rollout of the first on-line patient registry for pelvic radiation cancer survivors. The online registry is located at www.radiationcystitis.com The Bladder Health Foundation, with support from Lipella Pharmaceuticals Inc., is promoting the awareness of a serious bladder health condition, hemorrhagic ...
-
The Lancet Gastroenterology & Hepatology: Colorectal cancer incidence on the rise among young adults in several high-income countries
The incidence of colon and rectal cancer in adults younger than 50 years has increased substantially over the latest available 10-year period in several high-income countries, going against a decline or stabilisation trend in the incidence of colorectal cancers within the overall populations of high-income countries. This is according to an observational study published in The Lancet ...
By Siemens AG
-
Environmental contamination as a potential source of MRSA transmission
Ehsanollah Ghaznavi-Rad, MSc, of the Department of Medical Microbiology and Parasitology at the Universiti Putra Malaysia, and colleagues, report in a research brief in Infection Control & Hospital Epidemiology on a study they conducted to trace the source of nosocomial transmission of methicillin-resistant Staphylococcus aureus (MRSA) by investigating the impact of healthcare workers and the ...
-
Nature communications. ATP released by intestinal bacteria limits…
T cell dependent secretory IgA (SIgA) generated in the Peyer’s patches (PPs) of the small intestine shapes a broadly diverse microbiota that is crucial for host physiology. The mutualistic co-evolution of host and microbes led to the relative tolerance of host’s immune system towards commensal microorganisms. The ATP-gated ionotropic P2X7 receptor limits T follicular helper (Tfh) ...
-
EZ Glide Pushes Lumendi to New Quarter-Over-Quarter Sales Record
EZ Glide, the most recent enhancement to Lumendi’s DiLumen Endoluminal Interventional Platform (EIP), has achieved significant quarter-over-quarter product sales since its market introduction in Q4 2020, and is on track to double the sales revenue from the prior year. Launched in December 2020, EZ Glide is helping to significantly increase the platform’s useability in GI ...
By Lumendi Ltd.
-
Celixir publishes positive study results for potential cancer gene therapies showing cancer cell reduction in colon and breast cancer cell lines
Celixir publishes positive study results for potential cancer gene therapies showing cancer cell reduction in colon and breast cancer cell lines Promising cancer gene therapy programme using small interfering RNA (siRNA) Data from in vitro study published in PLOS journal Stratford-upon-Avon, UK, 13 May 2019 – Celixir, a privately-owned company discovering and developing life-saving ...
By Celixir plc
-
Comet Assay IV at the forefront of cancer research
Shown below are findings from some recent papers using Comet assay IV (http://www.scorecomets.com) for scoring comet assay slides: Investigations into Xanthohumol, a hop derived prenylated flavonoid found in beer, suggest that it protects against DNA damage induced by a common cooked food mutagen in rat colon mucosa and liver cells [1]. A small clinical study in healthy adult volunteers ...
By Instem Group
-
Creative Enzymes Probiotics Expands Service Offering with the Launch of Bifidobacterium Strains
Creative Enzymes, a professional and experienced supplier of enzymes, has a great reputation in the industry. With the continuous expansion of business areas and scale, the company has set foot in other areas and established a sound probiotic production and supply chain. The product manager of the Probiotics division is excited to announce the launch of Bifidobacterium strains to support your ...
-
Posters Presented at DDW 2022 Demonstrate G-Tech System Motility Measurements Correlate with Antroduodenal Manometry Measurements and Can be Used to Characterize Colon Motility Alteration
MOUNTAIN VIEW, Calif., May 26, 2022 – G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced that two posters were presented at Digestive Disease Week Conference held in San Diego in from May 21 through May 24. The first poster, entitled Wireless non-invasive patches detect phase III of the migrating motor complex in ...
-
Nanobodies and CAR-T
Researchers from Boston Children’s Hospital and MIT took mini-antibodies from alpacas Bryson and Sanchez. Then they shrunk the mini-antibodies into even smaller nanobodies and engineered these nanobodies onto CAR-T cells. During this process, they discovered a new form of cell therapy. The goal is to enhance CAR-T cells’ targeting abilities by targeting immunosuppressive proteins in ...
By IMAPAC
-
CDC Issues New Guidance For Use of EPA-Registered Disifectants in Environmental Control of Candida auris for U.S. Healthcare Facilities
On February 17, 2017, the U.S. Environmental Protection Agency (EPA) announced that the Centers for Disease Control and Prevention (CDC) issued guidance revising its recommendation regarding controlling Candida auris (C. auris) infections in U.S. healthcare facilities. The CDC guidance now recommends a “thorough daily and terminal cleaning and disinfection” of patient rooms in which ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you